GLOBUS MEDICAL, INC. (GMED) Free cash flow 2016–2025
GLOBUS MEDICAL, INC. (GMED) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$588.8MFY2025 · since FY2016: $106.9M → $588.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $588.8M | +45.3% |
| FY2024 | $405.2M | +145.2% |
| FY2023 | $165.2M | +58.2% |
| FY2022 | $104.4M | -52.4% |
| FY2021 | $219.4M | +62.3% |
| FY2020 | $135.1M | +33.5% |
| FY2019 | $101.2M | -17.0% |
| FY2018 | $121.9M | +13.2% |
| FY2017 | $107.8M | +0.8% |
| FY2016 | $106.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GMED financial trends
GMED RevenueGMED Net incomeGMED Net marginGMED Gross profitGMED Gross marginGMED Operating incomeGMED Operating marginGMED Operating cash flowGMED Capital expendituresGMED Return on equityGMED Stock buybacksGMED Dividends paidGMED Total assetsGMED Total liabilitiesGMED Shareholders’ equityGMED overview →